Form 4: Zoetis Director Michael McCallister Increases Stake

Zoetis Inc. Director Michael B. McCallister purchased 3,000 shares of common stock at a weighted average price of $77.7578.

Summary

• Director Michael B. McCallister acquired 3,000 shares of Zoetis Inc. (ZTS) common stock.
• The purchase was executed on May 11, 2026, at a weighted average price of $77.7578 per share.
• The shares were purchased in multiple transactions ranging from $77.72 to $77.80.
• Following this transaction, the reporting person holds 24,524 shares indirectly through a family trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically reflects confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by a director increasing their equity stake in the company.
• The purchase was made at market prices, signaling belief in the current valuation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider buying by board members is generally viewed as a positive signal of long-term confidence in the company's strategic direction and financial health within the animal health sector.

Comparison to Industry Standards

• Insider purchases by directors are standard corporate governance activities and align with market practices for publicly traded companies in the pharmaceutical and animal health industries.

Related Party Transactions

• The shares are held in trusts where the reporting person and their spouse are trustees and beneficiaries.

Stakeholder Impact

• Shareholders may view this as a positive indicator of management alignment with long-term value creation.

Key Dates

Keywords

Zoetis, ZTS, Insider Trading, Form 4, Director Purchase, Equity Ownership